NEW YORK, March 30 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC Bulletin Board: IYXI), a specialty pharmaceutical company focused on niche drug delivery technologies and products, reported today that it will be announcing 2005 year-end results before the stock market opens this coming Monday, April 3, 2006. Inyx will also conduct a conference call with investors this coming Monday morning at 9:00 a.m. Eastern Daylight Time. Investors in the U.S. should call the following toll-free number: 877-407-0782. Outside the U.S., investors should call: 201-689-8567. All callers should phone in by 8:55 a.m. EDT. The call will also be webcast by Vcall, which can be accessed at Inyx's website: http://www.inyxgroup.com/ or at http://www.investorcalendar.com/. For those unable to access the call live, a replay will be available to U.S. investors at the following toll-free number: 877-660-6853; international investors should call: 201-612-7415. All replay callers must dial-in account number: 286 and conference I.D.: 198099. The replay will be available approximately two hours after the live call ends and run through 11:59 p.m. EDT on April 7, 2006. The webcast will be archived for 90 days on the two websites listed above. On the conference call, Inyx senior management will review the company's 2005 operating results, discuss material business developments and provide future guidance. About Inyx Inyx, Inc. is a specialty pharmaceutical company with niche drug delivery technologies and products for the treatment of respiratory, allergy, dermatological, topical and cardiovascular conditions. Inyx focuses its expertise on both prescription and over-the-counter pharmaceutical products, and provides specialty pharmaceutical development and production consulting services. In addition, Inyx is developing its own proprietary products. The company's operations are conducted through several wholly owned subsidiaries: Inyx USA, Ltd., based in Manati, Puerto Rico; Inyx Pharma Ltd. and Inyx Europe Limited, which owns and operates Ashton Pharmaceuticals Ltd., all near Manchester, England; Inyx Canada, Inc. in Toronto; and Exaeris, Inc., based in Exton, Pennsylvania. Inyx, Inc.'s corporate offices are in New York City. For more information, please visit: http://www.inyxinc.com/. Safe Harbor Statements about the Inyx's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. Inyx intends that such forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, Inyx's actual results could differ materially from expected results. For more information, please contact: Jay M. Green, Executive Vice President Inyx, Inc. DATASOURCE: Inyx, Inc. CONTACT: Jay M. Green, Executive Vice President of Inyx, Inc., Web site: http://www.inyxinc.com/

Copyright